A detailed history of Voya Investment Management LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 29,580 shares of TNDM stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,580
Previous 30,193 2.03%
Holding current value
$1.1 Million
Previous $1.22 Million 3.13%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.21 - $47.3 $21,583 - $28,994
-613 Reduced 2.03%
29,580 $1.25 Million
Q2 2024

Dec 03, 2024

BUY
$30.43 - $53.43 $18,653 - $32,752
613 Added 2.07%
30,193 $1.22 Million
Q2 2024

Aug 14, 2024

BUY
$30.43 - $53.43 $338,138 - $593,714
11,112 Added 58.24%
30,193 $1.22 Million
Q1 2024

Dec 06, 2024

SELL
$22.09 - $35.41 $231,922 - $371,769
-10,499 Reduced 35.49%
19,081 $675,000
Q1 2024

May 15, 2024

SELL
$22.09 - $35.41 $10,559 - $16,925
-478 Reduced 2.44%
19,081 $675,000
Q4 2023

Feb 14, 2024

SELL
$14.28 - $31.03 $24,318 - $52,844
-1,703 Reduced 8.01%
19,559 $578,000
Q3 2023

Nov 14, 2023

SELL
$19.33 - $36.22 $126,147 - $236,371
-6,526 Reduced 23.48%
21,262 $441,000
Q2 2023

Aug 14, 2023

SELL
$24.18 - $42.46 $760,847 - $1.34 Million
-31,466 Reduced 53.1%
27,788 $681,000
Q1 2023

May 15, 2023

SELL
$35.86 - $46.5 $506,379 - $656,626
-14,121 Reduced 19.24%
59,254 $2.41 Million
Q4 2022

Feb 14, 2023

SELL
$35.49 - $56.15 $1.74 Million - $2.75 Million
-48,977 Reduced 40.03%
73,375 $3.3 Million
Q3 2022

Mar 03, 2023

BUY
$43.76 - $68.97 $2.14 Million - $3.38 Million
48,977 Added 66.75%
122,352 $5.85 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $17.5 Million - $27.5 Million
-399,379 Reduced 76.55%
122,352 $5.86 Million
Q2 2022

Aug 15, 2022

BUY
$53.22 - $123.09 $241,033 - $557,474
4,529 Added 0.88%
521,731 $30.9 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $16.1 Million - $23.7 Million
157,768 Added 43.89%
517,202 $60.1 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $10.7 Million - $13.8 Million
-90,355 Reduced 20.09%
359,434 $54.1 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $1.2 Million - $1.67 Million
-12,870 Reduced 2.78%
449,789 $53.7 Million
Q2 2021

Aug 16, 2021

SELL
$77.0 - $100.19 $55.8 Million - $72.7 Million
-725,287 Reduced 61.05%
462,659 $45.1 Million
Q1 2021

May 17, 2021

SELL
$81.28 - $104.34 $13.6 Million - $17.5 Million
-167,300 Reduced 12.34%
1,187,946 $105 Million
Q4 2020

Feb 16, 2021

BUY
$86.4 - $121.75 $26.3 Million - $37.1 Million
304,590 Added 28.99%
1,355,246 $130 Million
Q3 2020

Nov 16, 2020

BUY
$95.43 - $116.09 $54.6 Million - $66.4 Million
572,125 Added 119.56%
1,050,656 $119 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $2.26 Million - $3.72 Million
37,563 Added 8.52%
478,531 $47.3 Million
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $5.84 Million - $11.1 Million
-123,369 Reduced 21.86%
440,968 $28.4 Million
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $515,361 - $690,543
-9,700 Reduced 1.69%
564,337 $33.6 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $1.63 Million - $2.09 Million
28,458 Added 5.22%
574,037 $33.9 Million
Q2 2019

Aug 14, 2019

BUY
$54.41 - $71.7 $22.2 Million - $29.2 Million
407,444 Added 294.96%
545,579 $35.2 Million
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $466,947 - $1.07 Million
-14,479 Reduced 9.49%
138,135 $8.77 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $3.78 Million - $5.39 Million
132,710 Added 666.75%
152,614 $5.79 Million
Q3 2018

Nov 14, 2018

BUY
$21.39 - $51.17 $50,523 - $120,863
2,362 Added 13.46%
19,904 $853,000
Q2 2018

Aug 14, 2018

BUY
$4.9 - $23.64 $85,955 - $414,692
17,542 New
17,542 $386,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.